2.6100
+0.0600
+(2.35%)
At close: April 9 at 4:00:02 PM EDT
2.6801
+0.07
+(2.69%)
Pre-Market: 8:18:51 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-37,693
-37,693
-30,887
-33,820
-23,040
Investing Cash Flow
13,728
13,728
36,195
38,149
-131,448
Financing Cash Flow
53,780
53,780
--
75
35,450
End Cash Position
51,470
51,470
21,655
16,347
11,943
Income Tax Paid Supplemental Data
--
--
1
2
1
Capital Expenditure
-80
-80
-582
-1,006
-205
Issuance of Capital Stock
53,407
53,407
--
--
34,187
Free Cash Flow
-37,773
-37,773
-31,469
-34,826
-23,245
12/31/2021 - 7/27/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMUX Immunic, Inc.
0.9246
+3.31%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.5821
+9.83%
VSTM Verastem, Inc.
5.28
+13.67%
ALDX Aldeyra Therapeutics, Inc.
1.9400
+1.04%
MIST Milestone Pharmaceuticals Inc.
0.7233
+10.78%
SLS SELLAS Life Sciences Group, Inc.
1.1200
+7.69%
TRVI Trevi Therapeutics, Inc.
5.40
+1.89%
MESO Mesoblast Limited
11.08
+10.47%
TERN Terns Pharmaceuticals, Inc.
2.3000
+12.20%
PDSB PDS Biotechnology Corporation
1.0000
+6.94%